BEACON-IPF – A Phase 2 Clinical Trial
BEACON-IPF is a randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of bexotegrast (PLN-74809) for the treatment of idiopathic pulmonary fibrosis (IPF). Dr. Gregory P. Cosgrove, Medical […]